GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (XTER:7XP) » Definitions » Net Interest Income

Organon (XTER:7XP) Net Interest Income : €-486 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Organon Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Organon's net interest income for the three months ended in Mar. 2024 was €-121 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2024 was €-486 Mil.

Organon Net Interest Income Historical Data

The historical data trend for Organon's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Net Interest Income Chart

Organon Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Interest Income
Get a 7-Day Free Trial - - -228.33 -398.37 -483.26

Organon Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -123.29 -121.84 -125.56 -118.29 -120.52

Organon Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-486 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organon Net Interest Income Related Terms

Thank you for viewing the detailed overview of Organon's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon (XTER:7XP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (XTER:7XP) » Definitions » Net Interest Income
Comparable Companies
AMRN SCLX MIRA LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD LSE:GSK TSE:4568 TSE:4519 XTER:BAYN SHSE:600276
Traded in Other Exchanges
OGN:USA OGN:Mexico 1OGN:Italy 0A9W:UK
Address
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Website
https://www.organon.com
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.

Organon (XTER:7XP) Headlines

No Headlines